Defensive stocks have continued to top the list of safe plays for investors in 2009. With the U.S. government's $900 billion fiscal stimulus still being considered by the Senate, many are hopeful, yet cautious about where they should be putting their money right now.
An investor on CNBC Asia Pacific's "Protect Your Wealth" said she was banking on healthcare and consumer staples.
"We feel that going forward, the market is going to focused more on innovation. And we think the big pharmaceutical companies will be under pressure even though they are quite cash-rich," Daphne Roth, head of equity Research for Asia at ABN AMRO Private Bank said. "But they will be under pressure from patent expiry, from generic competition. So we are looking at companies that can still produce some pipeline discovery, like more on the biotech side."